mhurhangee/patent-ind-claim-en huggingface dataset:
An ophthalmic composition consisting of: an aqueous solution of hyaluronic acid (HA) or a pharmaceutically acceptable salt thereof; polyvinyl pyrrolidone (PVP); a quantity of an inorganic salt sufficient to bring the composition to a predetermined osmolarity; strong acid or strong base as necessary to bring the composition to a predetermined pH; and optionally, a buffer; characterized in that said ophthalmic composition is topically administrable ; and said ophthalmic composition is characterized by a concentration of HA or a pharmaceutically acceptable salt thereof of about 0.1% w/v and a concentration of PVP of about 5% w/v, wherein the term "about" refers to quantities within ±25% of the stated quantity. an aqueous solution of hyaluronic acid (HA) or a pharmaceutically acceptable salt thereof; polyvinyl pyrrolidone (PVP); a quantity of an inorganic salt sufficient to bring the composition to a predetermined osmolarity; strong acid or strong base as necessary to bring the composition to a predetermined pH; and optionally, a buffer;
A side airbag for vehicle which is deployed to a side of a seat comprising: an inflator part that discharges an inflation gas; and a cushion part that covers the inflator part , and is deployed by the gas discharged from the inflator part , wherein the cushion part includes a main chamber part that is deployed between a passenger and a vehicle body and that is disposed between a passenger and the vehicle body in a deployed state, and a protruding chamber part that extends from the main chamber part and is deployed in front of the passenger and is disposed in front of the passenger seated on the seat during deployment, characterized in that , the protruding chamber part has a shape that is bent or rolled in a direction in which the passenger is located when deployed, wherein the protruding chamber part of the cushion part installed on a left side of the seat is bent or rolled in a clockwise direction from an upper viewpoint, and the protruding chamber part of the cushion part installed on a right side of the seat is bent or rolled in a counterclockwise direction from the upper viewpoint, wherein in a state in which the protruding chamber part is bent or rolled, a part of an outer surface of the protruding chamber part is fixed to an outer surface of the cushion part. an inflator part that discharges an inflation gas; and a cushion part that covers the inflator part , and is deployed by the gas discharged from the inflator part , wherein the cushion part includes a main chamber part that is deployed between a passenger and a vehicle body and that is disposed between a passenger and the vehicle body in a deployed state, and a protruding chamber part that extends from the main chamber part and is deployed in front of the passenger and is disposed in front of the passenger seated on the seat during deployment, characterized in that , the protruding chamber part has a shape that is bent or rolled in a direction in which the passenger is located when deployed, wherein the protruding chamber part of the cushion part installed on a left side of the seat is bent or rolled in a clockwise direction from an upper viewpoint, and the protruding chamber part of the cushion part installed on a right side of the seat is bent or rolled in a counterclockwise direction from the upper viewpoint, wherein in a state in which the protruding chamber part is bent or rolled, a part of an outer surface of the protruding chamber part is fixed to an outer surface of the cushion part.
Composition for use in the prophylactic and therapeutic treatment of CMV-infections, characterized in that said composition contains piroxicam in a carrier substance.
A penile prosthetic comprising: a penile implant sized for insertion into a dilated corpora cavernosum of a penis, the penile implant includes a proximal tip that is insertable into a crus penis and an inflatable bladder connected to the proximal tip , the inflatable bladder has a first column strength and includes a distal tip that is insertable into a glans penis; and ; an insertion tool contained inside of the inflatable bladder wherein the insertion tool provides the inflatable bladder with an effective column strength that is greater than the first column strength, characterized in that the insertion tool is dissolvable in an aqueous liquid. a penile implant sized for insertion into a dilated corpora cavernosum of a penis, the penile implant includes a proximal tip that is insertable into a crus penis and an inflatable bladder connected to the proximal tip , the inflatable bladder has a first column strength and includes a distal tip that is insertable into a glans penis; and ; an insertion tool contained inside of the inflatable bladder wherein the insertion tool provides the inflatable bladder with an effective column strength that is greater than the first column strength, characterized in that the insertion tool is dissolvable in an aqueous liquid.
Zig-zag folded stack of paper web, in particular zig-zag folded stack of recycling paper web, wherein at least one fold of the zig-zag folded stack of paper web is formed with a perforation-tie-row , wherein ties of the fold couple two fold-web-sheets folded above one another, wherein the ties and the perforations each have a maximal longitudinal extension (x i ; y i ) in longitudinal fold direction (q), wherein several sections of a fold each comprise a perforation-tie-row of at least five alternatingly arranged ties and perforations each, wherein a ratio of a summed total longitudinal extension of the ties within each fold section with respect to a summed total longitudinal extension of the perforations of the same number within the fold section is larger than or equal to 1, wherein the single longitudinal extension (x i ) of each tie within each fold section is at least as large as the single longitudinal extension (y i ) of each perforation within the fold section, wherein at least one tie is larger than 1.5 mm, preferably larger than 2 mm or 5 mm.
A method of wireless communication performed by a user equipment, UE, comprising: receiving , from a base station, BS, serving the UE, information regarding reference beams and one or more event triggers associated with the reference beams, wherein the reference beams comprise beams associated with the serving BS and beams associated with a neighboring BS; detecting one of the event triggers, wherein the event trigger is detected based on a combined signal strength measurement of the beams associated with the neighboring BS exceeding a combined signal strength measurement of the beams associated with the serving BS; and taking one or more actions based, at least in part, on the detected event trigger. receiving , from a base station, BS, serving the UE, information regarding reference beams and one or more event triggers associated with the reference beams, wherein the reference beams comprise beams associated with the serving BS and beams associated with a neighboring BS; detecting one of the event triggers, wherein the event trigger is detected based on a combined signal strength measurement of the beams associated with the neighboring BS exceeding a combined signal strength measurement of the beams associated with the serving BS; and taking one or more actions based, at least in part, on the detected event trigger.
A stent comprising a core structure of a bioabsorbable magnesium alloy, a first coating layer of a first polymer with biodegradability, and a second coating layer of a second polymer with biodegradability, wherein the first coating layer covers the whole surface of the core structure; the second coating layer covers a part or the whole surface of the first coating layer ; the first polymer has a glass transition point of lower than 37°C; and the second polymer has a glass transition point of 47°C or higher, characterized in that the combination of the first polymer and the second polymer is, as combinations of first polymer/second polymer, PCL/PDLLA or PLCL/PDLLA, and wherein a composite is formed in the interface between the first coating layer and the second coating layer .
A data interface configuration method, comprising: receiving , by a second device, an application program command word sent by a first device after the first device starts an application program, the application program command word being corresponding to the application program; parsing , by the second device, the application program command word; obtaining, by the second device, a type of a function module corresponding to the application program command word based on a preset mapping relationship; and connecting , by the second device, a data interface to the function module corresponding to the application program command word; wherein the function module is invoked by running the application program on the first device after the function module is connected to the data interface; wherein the data interface is a data interface on the second device, and the function module is a function module in the second device; wherein the function module is hardware resources in the second device, the function module is corresponding to the application program software and the application program software is installed at the first device. receiving , by a second device, an application program command word sent by a first device after the first device starts an application program, the application program command word being corresponding to the application program; parsing , by the second device, the application program command word; obtaining, by the second device, a type of a function module corresponding to the application program command word based on a preset mapping relationship; and connecting , by the second device, a data interface to the function module corresponding to the application program command word; wherein the function module is invoked by running the application program on the first device after the function module is connected to the data interface; wherein the data interface is a data interface on the second device, and the function module is a function module in the second device; wherein the function module is hardware resources in the second device, the function module is corresponding to the application program software and the application program software is installed at the first device.
A method for preparing a suspension of gas-filled microvesicles stabilized by a layer of amphiphilic material which comprises a phospholipid, said method comprising: - providing a first fluid flow and, separately, a liquid flow comprising said amphiphilic material, wherein said first fluid flow is a gas; - directing said first fluid flow and said liquid flow through respective inlet channels towards a contact zone; - directing said first fluid flow and said liquid flow from the contact zone through a calibrated orifice to obtain a suspension comprising said microvesicles; and - directing said suspension comprising said microvesicles towards an outlet channel ; wherein an initial portion of said outlet channel is kept at a controlled temperature (°C) of not less than 20% lower with respect to the transition temperature of the amphiphilic material. - providing a first fluid flow and, separately, a liquid flow comprising said amphiphilic material, wherein said first fluid flow is a gas; - directing said first fluid flow and said liquid flow through respective inlet channels towards a contact zone; - directing said first fluid flow and said liquid flow from the contact zone through a calibrated orifice to obtain a suspension comprising said microvesicles; and - directing said suspension comprising said microvesicles towards an outlet channel ;
An enteral tube for placement within a patient, comprising: a tube having a distal end portion for placement within a patient and a proximal end portion , said tube having a lumen increasing in cross section along at least a portion of the distal end portion toward a distal end .
A catalyst composition for the oligomerization of ethylene comprising: a catalyst comprising zirconium; and a co-catalyst; wherein the co-catalyst comprises ethylaluminum sesquichloride (EASC) and diethyl aluminum chloride (DEAC) in a EASC to DEAC mass ratio 1:1 to 10:1; and wherein Al:Zr molar ratio in the catalyst composition is 1:1 to 50:1. a catalyst comprising zirconium; and a co-catalyst; wherein the co-catalyst comprises ethylaluminum sesquichloride (EASC) and diethyl aluminum chloride (DEAC) in a EASC to DEAC mass ratio 1:1 to 10:1; and wherein Al:Zr molar ratio in the catalyst composition is 1:1 to 50:1.
A communication device (102; 300) comprising a casing which houses a battery , the battery extending in a main extension plane , wherein the casing comprises a back cover which is configured to cover the battery , the back cover extending in a second plane substantially parallel to the main extension plane , wherein the communication device (102; 300) comprises an electrical signal transmission line comprising a first portion and a second portion , wherein the second portion is connected to a processing unit of the communication device , wherein the first portion along its longitudinal extension is connected to at least one electrical component (116; 313), and wherein the first portion extends alongside the battery in a third plane substantially perpendicular to the main extension plane ; wherein each of the at least one electrical component is an antenna radiating element ; characterised in that : the first portion of the electrical signal transmission line is connected to each of the at least one electrical component (116; 313) by a respective resilient contact which is attached and connected to the first portion of the electrical signal transmission line , each electrical component (116; 313) having a contact portion (130; 312), wherein the resilient contact resiliently abuts against the contact portion (130; 312) of the electrical component (116; 313); and each antenna radiating element is attached to the back cover . wherein each of the at least one electrical component is an antenna radiating element ; characterised in that : the first portion of the electrical signal transmission line is connected to each of the at least one electrical component (116; 313) by a respective resilient contact which is attached and connected to the first portion of the electrical signal transmission line , each electrical component (116; 313) having a contact portion (130; 312), wherein the resilient contact resiliently abuts against the contact portion (130; 312) of the electrical component (116; 313); and each antenna radiating element is attached to the back cover . the first portion of the electrical signal transmission line is connected to each of the at least one electrical component (116; 313) by a respective resilient contact which is attached and connected to the first portion of the electrical signal transmission line , each electrical component (116; 313) having a contact portion (130; 312), wherein the resilient contact resiliently abuts against the contact portion (130; 312) of the electrical component (116; 313); and each antenna radiating element is attached to the back cover .
A synthetic layer scaffold for rebuilding a diseased intima layer of an artery, comprising: a biocompatible, bioresorbable synthetic elastic intima layer deployable on an inner surface of a diseased artery, wherein the synthetic elastic intima layer is a polymer layer with a thickness less than 0.004 inches (100 μm); wherein the synthetic elastic intima layer has pores to allow the outer surface to adhere to the inner surface wall of the diseased artery upon delivery in the artery and to allow cell ingrowth upon the delivery in the artery, wherein the diameter of the pores is between 1 to 10,000 microns; wherein the synthetic elastic intima layer is bio-absorbable over time upon the delivery in the artery; and wherein the bio-absorbable synthetic elastic intima layer is capable of being replaced by a newly rebuilt intima layer as a result of the cell ingrowth and the adherence of the outer surface of the bio-absorbable synthetic elastic intima layer to the inner surface wall of the artery. a biocompatible, bioresorbable synthetic elastic intima layer deployable on an inner surface of a diseased artery, wherein the synthetic elastic intima layer is a polymer layer with a thickness less than 0.004 inches (100 μm); wherein the synthetic elastic intima layer has pores to allow the outer surface to adhere to the inner surface wall of the diseased artery upon delivery in the artery and to allow cell ingrowth upon the delivery in the artery, wherein the diameter of the pores is between 1 to 10,000 microns; wherein the synthetic elastic intima layer is bio-absorbable over time upon the delivery in the artery; and wherein the bio-absorbable synthetic elastic intima layer is capable of being replaced by a newly rebuilt intima layer as a result of the cell ingrowth and the adherence of the outer surface of the bio-absorbable synthetic elastic intima layer to the inner surface wall of the artery.
Device for a medical instrument for applying a surgical suture, comprising a release unit and an operating unit , wherein the operating unit has two pivotable gripper jaws , wherein each gripper jaw comprises a needle receptacle and a needle-fixing device, wherein the release unit is adapted for moving the two gripper jaws and additionally for actuating the needle-fixing device, and wherein the needle-fixing device has at least one pawl element which is movable via the release unit , wherein the at least one pawl element cooperates with a gear element , characterised in that the gear element has two gears , which are arranged substantially plane-parallel to one another and have a different number of teeth .
A liquid container configured to be detachably attached to a main body portion of an apparatus, the liquid container comprising: a container main body including an upper portion , a bottom portion , and side portions connecting the upper portion and the bottom portion , the container main body being capable of storing a liquid (W); a first ventilation hole , and second ventilation hole each penetrating the upper portion of the container main body , the first ventilation hole and the second ventilation hole are open in a same direction; and a first lid , and a second lid , each disposed on an inner side of the container main body and, when the liquid (W) is stored in the container main body , the first lid and the second lid are capable of closing or opening the first ventilation hole and the second ventilation hole , respectively, according to a change in a surface of the liquid (W); at least one of the lids including a fulcrum positioned closer to the side portion of the container main body than the ventilation hole , and the at least one of the lids being pivotable around the fulcrum with respect to the ventilation hole . a container main body including an upper portion , a bottom portion , and side portions connecting the upper portion and the bottom portion , the container main body being capable of storing a liquid (W); a first ventilation hole , and second ventilation hole each penetrating the upper portion of the container main body , the first ventilation hole and the second ventilation hole are open in a same direction; and a first lid , and a second lid , each disposed on an inner side of the container main body and, when the liquid (W) is stored in the container main body , the first lid and the second lid are capable of closing or opening the first ventilation hole and the second ventilation hole , respectively, according to a change in a surface of the liquid (W); at least one of the lids including a fulcrum positioned closer to the side portion of the container main body than the ventilation hole , and the at least one of the lids being pivotable around the fulcrum with respect to the ventilation hole .
A computer-implemented method for radiation therapy treatment planning, comprising: a. obtaining a protocol plan, which has been created by applying a plan generation protocol to a set of patient data for a current patient, said set of patient data comprising at least one planning image; b. calculating at least one protocol DVH curve, each protocol DVH curve relating a dose distribution for the protocol plan to a volume of a structure in a structure set associated with the at least one planning image; c. obtaining estimated clinical DVH curves for the current patient by sending the at least one protocol DVH curve for the current patient as a query to a prediction model, the prediction model being arranged to determine estimated clinical DVH curves for the current patient on the basis of protocol DVH curves for the current patient based on a relationship between protocol DVH curves and clinical DVH curves for a collection of previous patients; d. using at least one of the estimated clinical DVH curves in treatment planning for the current patient. a. obtaining a protocol plan, which has been created by applying a plan generation protocol to a set of patient data for a current patient, said set of patient data comprising at least one planning image; b. calculating at least one protocol DVH curve, each protocol DVH curve relating a dose distribution for the protocol plan to a volume of a structure in a structure set associated with the at least one planning image; c. obtaining estimated clinical DVH curves for the current patient by sending the at least one protocol DVH curve for the current patient as a query to a prediction model, the prediction model being arranged to determine estimated clinical DVH curves for the current patient on the basis of protocol DVH curves for the current patient based on a relationship between protocol DVH curves and clinical DVH curves for a collection of previous patients; d. using at least one of the estimated clinical DVH curves in treatment planning for the current patient.
A device comprising: a blood glucose measurement unit configured to obtain a measure of a glucose level of a sample of blood from a user; a determining unit configured to : a) use information provided by one or more sensors to calculate a measure of physical activity of the user, to determine a level of intensity of activity in each of plural consecutive time periods and to record the intensity information along with an indication of the associated time period in a storage unit ; b) calculate a medicament dose using at least the measured glucose level, the measure of physical activity of the user, and a time elapsed between an instance of physical activity and a current time; and a display unit configured to indicate the calculated medicament dose to the user, characterized in that the calculation of the medicament dose comprises giving a higher weighting to a period of physical activity occurring more recently with respect to the current time than other periods of physical activity. a blood glucose measurement unit configured to obtain a measure of a glucose level of a sample of blood from a user; a determining unit configured to : a) use information provided by one or more sensors to calculate a measure of physical activity of the user, to determine a level of intensity of activity in each of plural consecutive time periods and to record the intensity information along with an indication of the associated time period in a storage unit ; b) calculate a medicament dose using at least the measured glucose level, the measure of physical activity of the user, and a time elapsed between an instance of physical activity and a current time; and a display unit configured to indicate the calculated medicament dose to the user, characterized in that the calculation of the medicament dose comprises giving a higher weighting to a period of physical activity occurring more recently with respect to the current time than other periods of physical activity.